Collectively, these emerging data indicate that CD4+ T cells in pristane-treated mice with activation markers can promote IgG production, which is critical in the induction of pathological autoantibodies in pristane-induced lupus mice. This evidence concerns the gene CD4 and systemic lupus erythematosus.